A Straight from the Source Webinar
Review by Exception is the ultimate goal of Electronic Batch Records (EBR) and Manufacturing Execution System (MES) implementations at Life-Science organizations. Yet few industry companies have achieved this goal.
Fujirebio Diagnostics Inc., (FDI) is undergoing Digital Transformation, starting with MES / EBR implementation, resulting in a Review by Exception approach for manufacturing batch records.
Join FDI’s Samantha Schloth and Axendia’s Daniel R. Matlis for a live webinar on August 6 at 11:00 AM ET to learn how Digital Transformation is enabling Review by Exception and reducing manufacturing cycle times.
We will discuss:
- Undergoing Digital Transformation
- Leveraging FDA’s Risk Based Computer System Assurance Approach
- An Implementation Strategy for success
- Moving from Paper to Digital Records
- The Value of Review by Exception
- Lessons learned, challenges and opportunities
Meet Your Trusted Sources
Can’t attend the live webinar? Register to receive a link to the on-demand recording after the event.